Indoximod and Provenge Combo Lengthens Time for Prostate Cancer to Progress, Trial Shows
News
A combination of NewLink Genetics‘ immunotherapy indoximod and the cancer vaccine Provenge more than doubled the time it took for an advanced cancer patient’s disease to progress, compared with Provenge alone, ... Read more